The Marketing Authorisation Holder and not the Responsible Person must ensure that a reporting system is in place. For this purpose, they must appoint a Responsible Person PV to fulfil the reporting obligations (cf. Art. 59 (HMG) of the Swiss Medicinal Products Act, Art. 7 (AMBV) of the Swiss Medicinal Products Approval Ordinance).
Dr. Katharina Oehler
Scientific and Managing Director
Send email